dean22029/WTO_Docs huggingface dataset:
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 10 December 2021
Document codes: WT/DS291/37/Add.160; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 9 December 2021, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to continue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 14 January 2022
Document codes: WT/DS291/37/Add.161; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 13 January 2022, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to continue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 18 February 2022
Document codes: WT/DS291/37/Add.162; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 17 February 2022, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to continue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 18 March 2022
Document codes: WT/DS291/37/Add.163; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 17 March 2022, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to continue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 14 April 2022
Document codes: WT/DS291/37/Add.164; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 13 April 2022, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to continue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 20 May 2022
Document codes: WT/DS291/37/Add.165; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 19 May 2022, from the delegation of the European Union to the
Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to continue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 20 June 2022
Document codes: WT/DS291/37/Add.166; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 17 June 2022, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to conti nue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 11 July 2022
Document codes: WT/DS291/37/Add.167; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 8 July 2022, from the delegation of the European Union to the
Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to conti nue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 19 August 2022
Document codes: WT/DS291/37/Add.168; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 17 August 2022, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to conti nue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 13 September 2022
Document codes: WT/DS291/37/Add.169; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 12 September 2022, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the DSB Recommendations
and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to conti nue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 14 October 2022
Document codes: WT/DS291/37/Add.170; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 13 October 2022, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to conti nue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 18 November 2022
Document codes: WT/DS291/37/Add.171; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 17 November 2022, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to conti nue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 9 December 2022
Document codes: WT/DS291/37/Add.172; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 8 December 2022, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to conti nue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 17 January 2023
Document codes: WT/DS291/37/Add.173; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 16 January 2023, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 17 February 2023
Document codes: WT/DS291/37/Add.174; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 16 February 2023, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 21 March 2023
Document codes: WT/DS291/37/Add.175; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 20 March 2023 , from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 18 April 2023
Document codes: WT/DS291/37/Add.176; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 17 April 2023, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 17 May 2023
Document codes: WT/DS291/37/Add.177; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 16 May 2023, from the delegation of the European Union to the
Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 20 June 2023
Document codes: WT/DS291/37/Add.178; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 19 June 2023, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 18 July 2023
Document codes: WT/DS291/37/Add.179; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 17 July 2023, from the delegation of the European Union to the
Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 6 September 2023
Document codes: WT/DS291/37/Add.180; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 5 September 2023, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 16 October 2023
Document codes: WT/DS291/37/Add.181; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 13 October 2023, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 17 November 2023
Document codes: WT/DS291/37/Add.182; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 16 November 2023, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 11 December 2023
Document codes: WT/DS291/37/Add.183; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 7 December 2023, from the delegation of the European Union
to the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 16 January 2024
Document codes: WT/DS291/37/Add.184; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 15 January 2024, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 8 March 2024
Document codes: WT/DS291/37/Add.185; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 7 March 2024, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 16 April 2024
Document codes: WT/DS291/37/Add.186; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 15 April 2024, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 14 May 2024
Document codes: WT/DS291/37/Add.187; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 13 May 2024, from the delegation of the European Union to the
Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 14 June 2024
Document codes: WT/DS291/37/Add.188; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 13 June 2024, from the delegation of the European Union to
the Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to contin ue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS STATUS REPORT BY THE EUROPEAN UNION
Document: Addendum
Date: 16 July 2024
Document codes: WT/DS291/37/Add.189; WT/DS293/41; WT/DS292/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
STATUS REPORT BY THE EUROPEAN UNION
Addendum
The following communication, dated 15 July 2024, from the delegation of the European Union to the
Chairperson of the Dispute Settlement Body, is circulated pursuant to Article 21.6 of the DSU.

Status Report Regarding Implementation of the
DSB Recommendations and Rulings in the Dispute
European Communities – Measures Affecting the Approval
and Marketing of Biotech Products
(WT/DS291)

Following the mutually agreed solutions reached with Argentina (document ) and
Canada (), the European Union remains ready to continue its discussions with the
United States with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Recourse by the European Communities to Article 22.6 of the DSU Communication from the Arbitrator
Date: 19 February 2008
Document codes: WT/DS291/42
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Recourse by the European Communities to Article 22.6 of the DSU

Communication from the Arbitrator

 The following communication, dated 15 Febr uary 2008, has been received from the
delegation of the European Communities and the delegation of the United States and addressed to
Mr. Christian Häberli, Chairman of the Arbitrator:

"The European Communities and the United St ates (the 'Parties') wish to thank you
and the other arbitrators for accepting to serve in the above-captioned proceeding.
On 14 January 2008, the Parties reached agreement on certain procedures under
Articles 21 and 22 of the DSU () (the 'Agreed Procedures').
Paragraph 2 of the Agreed Procedures states the following:
After the referral of the matter to Ar ticle 22.6 arbitration, the parties
will request the Article 22.6 arbitrator, at the earliest possible
moment, to suspend its work. The arbitration will resume if and
when the condition in paragraph 6 is fulfilled.
Paragraphs 3 to 5 of the Agreed Procedur es set out the procedure to be followed to
initiate compliance proceedings under Article 21.5 of the DSU.
Paragraph 6 of the Agreed Procedures provides as follows:
In the event that the DSB finds that a measure taken to comply with
the recommendations and rulings of the DSB in this dispute does not
exist or is inconsistent with a covered agreement, the Article 22.6
arbitrator will resume its work at the request of the United States.
Accordingly, the Parties hereby request the Arbitrator to suspend its work. As noted,
the Parties have agreed that the arbitrati on will resume at the request of the United
States if and when the DSB finds that a measure taken to comply with the
recommendations and rulings of the DSB in this dispute does not exist or is
inconsistent with a covered agreement."

 In accordance with the parties' joint request , the Arbitrator has suspended the arbitration
proceedings from 18 February 2008 until the Unit ed States requests their resumption under the
circumstances agreed between the parties on 14 January 2008.